CAS 55-27-6|DL-Norepinephrine hydrochloride
| Common Name | DL-Norepinephrine hydrochloride | ||
|---|---|---|---|
| CAS Number | 55-27-6 | Molecular Weight | 205.639 |
| Density | 1.397g/cm3 | Boiling Point | 442.6ºC at 760mmHg |
| Molecular Formula | C8H12ClNO3 | Melting Point | 140-144ºC (dec.) |
| MSDS | USA | Flash Point | 221.5ºC |
| Symbol | GHS06 | Signal Word | Danger |
Names
| Name | dl-noradrenaline hydrochloride |
|---|---|
| Synonym | More Synonyms |
DL-Norepinephrine hydrochloride BiologicalActivity
| Description | DL-Norepinephrine hydrochloride is a synthetic phenylethylamine that mimics the sympathomimetic actions of the endogenous norepinephrine.DL-Norepinephrine hydrochloride is a neurotransmitter targets α1 and β1 adrenoceptors, has an increasing effect on subendocardial oxygen tension[1]. |
|---|---|
| Related Catalog | Research Areas >>Endocrinology |
| Target | IC50: α1 adrenoceptor and β1 adrenoceptor[1] |
| References | [1]. Matsuda H, et al. Effects of nitroglycerin, adenosine, noradrenaline, and isoproterenol on the myocardial oxygen tension. Jpn Heart J. 1979 Nov;20(6):867-79. |
Chemical & Physical Properties
| Density | 1.397g/cm3 |
|---|---|
| Boiling Point | 442.6ºC at 760mmHg |
| Melting Point | 140-144ºC (dec.) |
| Molecular Formula | C8H12ClNO3 |
| Molecular Weight | 205.639 |
| Flash Point | 221.5ºC |
| Exact Mass | 205.050568 |
| PSA | 86.71000 |
| LogP | 1.59220 |
| Appearance of Characters | crystalline | off-white to tan |
| InChIKey | FQTFHMSZCSUVEU-UHFFFAOYSA-N |
| SMILES | Cl.NCC(O)c1ccc(O)c(O)c1 |
| Storage condition | 2-8°C |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 2 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 71,62,1941
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 15600 ug/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 92,369,1948
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 5 mg/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold Vascular - regional or general arteriolar constriction Lungs, Thorax, or Respiration - acute pulmonary edema
- REFERENCE :
- JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 92,108,1948 ** REPRODUCTIVE DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- DOSE :
- 13 mg/kg
- SEX/DURATION :
- female 7-19 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - behavioral
- REFERENCE :
- NYKZAU Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- Volume(issue)/page/year: 85,79,1985
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- DOSE :
- 3200 ng/kg
- SEX/DURATION :
- female 16 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetal death
- REFERENCE :
- PRGLBA Prostaglandins. (Geron-X, Inc., P.O. Box 1108, Los Altos, CA 94022) V.1- 1972- Volume(issue)/page/year: 2,295,1972
Safety Information
| Symbol | GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | P301 + P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T |
| Risk Phrases | R25 |
| Safety Phrases | 36/37/39-45 |
| RIDADR | UN 2811 |
| WGK Germany | 3 |
| RTECS | DN6650000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 2922509090 |
Customs
| HS Code | 2922509090 |
|---|---|
| Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Articles118
More Articles| Sympathetic activity induced by naloxone-precipitated morphine withdrawal is blocked in genetically engineered mice lacking functional CRF1 receptor. Toxicol. Appl. Pharmacol. 283(1) , 42-9, (2015) There is large body evidence indicating that stress can lead to cardiovascular disease. However, the exact brain areas and the mechanisms involved remain to be revealed. Here, we performed a series of... | |
| An assessment of norepinephrine mediated hypertrophy to apoptosis transition in cardiac cells: a signal for cell death. Chem. Biol. Interact. 225 , 54-62, (2015) Heart is an organ which is under a constant work load that generates numerous stress responses. Heart failure is associated with increased plasma norepinephrine (NE) and hypertrophic cell death. Withi... | |
| Relationship between noradrenaline release in the locus coeruleus and antiallodynic efficacy of analgesics in rats with painful diabetic neuropathy. Life Sci. 92(23) , 1138-44, (2013) In animal models of neuropathic pain, the noradrenergic descending pain inhibitory pathways from the locus coeruleus (LC) may be suppressed. However, no study has investigated the correlation between ... |
Synonyms
| NA hydrochloride |
| DL-NOREPINEPHRINE HCL |
| DL-NORADRENALIN HYDROCHLORIDE |
| UNII:7W3827X38V |
| Arterenol hydrochloride |
| EINECS 200-229-8 |
| MFCD00012880 |
| 4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol hydrochloride (1:1) |
| DL-Norepinephrine hydrochloride |
| 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, hydrochloride (1:1) |
| (±)-4-(2-amino-1-hydroxyethyl)-1,2-Benzenediol hydrochloride |
| 4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol hydrochloride (1:1) |
| DL-ARTERENOL HYDROCHLORIDE |
| DL-ARTERENOL |
